Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Gc Corp.

10% Owner at Artiva Biotherapeutics, Inc. (ARTV)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return+54.7%
vs. S&P 500+52.9%
Beat the market100%
Paper profit on buys−$6.6M
Total bought / sold$16.5M / $0

Reported trades

Filed Stock Type Shares Price Value Since
May 28SEC ARTVArtiva Biotherapeutics, Inc. Buy 1,085,0694,391,969 held (+33%) $11.52 $12.5M -39.8%
May 28SEC ARTVArtiva Biotherapeutics, Inc. Buy 347,2221,607,734 held (+28%) $11.52 $4.0M -39.8%
  • Buy

    10% Owner Gc Corp. bought $12.5M of ARTV at $11.52 — first open-market purchase in our records; raises the stake by 33%.

  • Buy

    10% Owner Gc Corp. bought $4.0M of ARTV at $11.52 — raises the stake by 28%.